Table 2.
Investigations in autoimmune encephalitis
Investigation | Expected results in autoimmune encephalitis | Notes |
EEG | Focal or diffuse slow activity +/− foci of epileptic activity (subclinical seizures)11 | |
Extreme delta brush pattern more specific and associated with worse outcome and increased likelihood of ICU admission33 | ||
MRI | Unilateral or bilateral hippocampal MRI FLAIR-T2 hyperintensities (typical of limbic encephalitis)5 | Not a sensitive investigation, even when marked neurological component.34 More useful for excluding other diagnoses (dementia, demyelinating conditions, vasculitis, tumour, etc) particularly in the elderly where these pathologies are more common. |
Transient contrast enhancement in medial temporal lobe(s) (especially in paraneoplastic encephalitis)5 | ||
18F-FDG-PET | Medial temporal lobe hypermetabolism35 | May be more sensitive than MRI but lower specificity.36 |
CSF | Pleocytosis (6–14 cells/µL) (may be earlier sign)37 | CSF antibodies are more relevant than serum (higher sensitivity and specificity, better correlation to clinical course with treatment)21 |
Oligoclonal bands (may be later sign)37 | ||
Specific autoantibodies | ||
Whole body PET/CT+/−US testes/ovaries | To look for a tumour if a paraneoplastic process suspected | |
ANA | Non-specific marker of systemic inflammation |
ANA, antinuclear antibodies; FDG-PET, fluorodeoxyglucose positron emission tomography; FLAIR2, fluid attunated inversion recovery/T2 weighted; ICU, intensive care unit; US, ultrasound.